RSV vaccine-enhanced disease is orchestrated by the combined actions of distinct CD4 T cell subsets.
There is no currently licensed vaccine for respiratory syncytial virus (RSV) despite being the leading cause of lower respiratory tract infections in children. Children previously immunized with a formalin-inactivated RSV (FI-RSV) vaccine exhibited enhanced respiratory disease following natural RSV...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2015-03-01
|
| Series: | PLoS Pathogens |
| Online Access: | http://europepmc.org/articles/PMC4358888?pdf=render |